E2F1 and non-small cell lung carcinoma: These data indicates that TAZ-AS202 promotes NSCLC pro-oncogenic properties through regulation of E2F1 protein, which in turn directly regulates the expression of a large set of target genes involved in cancer progression and aggressiveness.